Literature DB >> 1122674

The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.

R Gugler, W Höbel, G Bodem, H J Dengler.   

Abstract

The correlation between the beta receptor blocking activity of pindolol and plasma level was studied in 8 subjects after a 10-mg oral dose. Exercise tachycardia was markedly reduced over a period of at least 6 hr. Significant effects were recorded 30 min after the drug. For each individual there was a close correlation between log plasma level and beta blockade. The regression lines were parallel as shown by analysis of covariance; the intercepts, however, were significantly different. It can be concluded that there is a correlation between plasma level and beta adrenergic blockade by pindolol, but the data failed to establish in different individuals the blood levels necessary to achieve effective adrenergic blockade.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1122674     DOI: 10.1002/cpt1975172127

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

1.  Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.

Authors:  J F Giudicelli; C Richer; M Chauvin; N Idrissi; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

2.  Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.

Authors:  T Ishizaki; K Tawara
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

3.  Ocular and cardiovascular effects of local and systemic pindolol.

Authors:  S E Smith; S A Smith; F Reynolds; V B Whitmarsh
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

4.  Chronic propranolol administration during pregnancy. Maternal pharmacokinetics.

Authors:  M T Smith; I Livingstone; M J Eadie; W D Hooper; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Single and multiple dose pharmacokinetics of pindolol.

Authors:  R Gugler; G Bodem
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.

Authors:  L A Salako; A O Falase; A Ragon; R A Adio
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

8.  Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment.

Authors:  S Mann; M W Craig; V Balasubramanian; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

9.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.

Authors:  M B Finch; P C O'Connor; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.